Royalty Pharma plcRPRXNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-96.15%
↓ 263% below average
Average (9y)
59.07%
Historical baseline
Range
High:661.09%
Low:-96.15%
Volatility
1281.9%
High variability
| Period | Value |
|---|---|
| 2024 | -96.15% |
| 2023 | -70.64% |
| 2022 | -11.48% |
| 2021 | 661.09% |
| 2020 | -68.34% |
| 2019 | -78.85% |
| 2018 | 233.10% |
| 2017 | 29.49% |
| 2016 | -7.48% |
| 2015 | 0.00% |